A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastr
This is a phase III, multicenter, prospective, randomized, controlled clinical trial to evaluate the impact of omentectomy for advanced gastric cancer on patient survival.
| Condition(s) | Gastric Cancer |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This is a phase III, multicenter, prospective, randomized, controlled clinical trial to evaluate the impact of omentectomy for advanced gastric cancer on patient survival. |
| Who can participate | Inclusion Criteria: 1. Had been treated with Radical resection (D2, R0) of gastric cancer (Lymph node≥16); 2. Physical condition and organ function allows to tolerable abdominal surgery; 3. Willing and able to comply with the program during the study period; 4. Written informed consent provided; 5. ≥ 18 and ≤ 70 years of age; preoperative gastric cancer patients with pathologically confirmed; 6. With more than a 6-month life expectancy; 7. No other serious concomitant diseases; Sufficient organ functions; 8. No previous history of chemotherapy or radiotherapy; 9. All patients accept 8 cycles XELOX chemotherapy regimen; 10. Clinical stage: T3-4aN0-+M0; 11 . Macroscopic types :Borrmann I-III; 12\. Not greater curvature tumor; with distal or total gastrectomy； 13. No previous surgery for any |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Lead sponsor | Tianjin Medical University Cancer Institute and Hospital |
| Locations | Tianjin, Tianjin Municipality, China |
| Start date | 2021-01-01 |
| NCT ID | NCT04843215 |
| Official listing | https://clinicaltrials.gov/study/NCT04843215 |